EA
BHC icon

Euclid Advisors’s Bausch Health BHC Stock Holding History

Euclid Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-89,973
Closed -$2.37M – 554
2016
Q1 		$2.37M Sell
89,973
-6,167
-6% -$456K 0.09% 257
2015
Q4 		$9.77M Buy
96,140
+21,264
+28% +$2.39M 0.3% 121
2015
Q3 		$13.4M Buy
74,876
+24,902
+50% +$5.81M 0.6% 45
2015
Q2 		$11.1M Buy
49,974
+20,034
+67% +$4.44M 0.22% 154
2015
Q1 		$5.95M Sell
29,940
-910
-3% -$161K 0.11% 183
2014
Q4 		$4.42M Buy
30,850
+800
+3% +$108K 0.04% 300
2014
Q3 		$3.94M Sell
30,050
-100
-0.3% -$11.9K 0.03% 409
2014
Q2 		$3.8M Buy
30,150
+28,550
+1,784% +$3.64M 0.03% 402
2014
Q1 		$211K Buy
+1,600
New +$219K ﹤0.01% 397

Other funds holding BHC

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Euclid Advisors's BHC Position: Q2 2016 in Review

Euclid Advisors sold out of Bausch Health (BHC) in Q2 2016, closing a stake of 89,973 shares — an estimated $2.37M sold.

Euclid Advisors first reported a position in BHC in Q1 2014 and held it in 9 quarters. The position peaked at $13.4M in Q3 2015. 347 funds tracked by Wall St. Rank hold BHC as of Q2 2016.

  • Euclid Advisors reported no remaining Bausch Health position as of Q2 2016 after selling out during the quarter.
  • Euclid Advisors sold 89,973 Bausch Health shares in Q2 2016, an estimated $2.37M.
  • Euclid Advisors first reported a position in Bausch Health in Q1 2014 and held it in 9 quarters.
  • Euclid Advisors's Bausch Health position peaked at $13.4M in Q3 2015.
  • 347 funds tracked by Wall St. Rank held Bausch Health as of Q2 2016.

Based on Euclid Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.